Advertisement

Topics

Munich Leukemia Laboratory Company Profile

03:07 EDT 19th June 2019 | BioPortfolio


News Articles [1151 Associated News Articles listed on BioPortfolio]

Particle Testing Authority Opens European Laboratory in Munich, Germany and is Led by Noted Scientist Dr. Torben Sick

Particle Testing Authority (PTA), a division of Micromeritics Instrument Corporation, has announced the opening of its European laboratory in Munich, Germany. The laboratory focuses on material charac...

Live Commentary: Bayern Munich 1-2 Liverpool – Sports Mole

Live Commentary: Bayern Munich 1-2 Liverpool Sports MoleBayern Munich v Liverpool: Champions League last 16, second leg – live! The GuardianJurgen Klopp says it is 'mad' to think Liverpool Champio...

Presence of Leukemia Cutis Tied to Worse Survival in AML

THURSDAY, April 11, 2019 -- For patients with acute myeloid leukemia (AML), the presence of leukemia cutis (LC) is associated with decreased overall and leukemia-specific survival, according to a stud...

Munich s first GDP pharma certificate awarded to Cargogate

Cargogate, a provider of cargo handling services and a 100% subsidiary of Munich Airport since 1974, has been awarded the designation of pharma-certified warehouse, receiving Munich s first GDP certif...

“Super Drug” for Pediatric Leukemia Could Become Reality

Investigators at the Northwestern University Feinberg School of Medicine have just presented new data that shows when a key protein responsible for leukemia—dubbed mixed-lineage leukemia 1 (MLL1)—...

Medical News Today: Is leukemia hereditary?

Leukemia is a genetic condition, but in most cases, it is not hereditary. In this article, we explore the links between leukemia and family history, genetics, and lifestyle and environmental factors.

FDA Grants Priority Review to Daiichi Sankyo’s Quizartinib for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukemia

TOKYO, MUNICH and BASKING RIDGE, N.J., Nov. 21, 2018 /PRNewswire/ — Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) has acc...

Study Adds Evidence on The Link Between Leukemia Cutis and Poor Prognosis in AML

A recent study in JAMA Dermatology evaluated overall and leukemia-specific survival in patients with AML and leukemia cutis vs AML alone.

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

P32 sodium phosphate [anazaohealth corporation]

P32 Sodium Phosphate

Venclexta [abbvie inc.]

These highlights do not include all the information needed to use VENCLEXTA safely and effectively. See full prescribing information for VENCLEXTA. VENCLEXTA (venetoclax tablets) for oral use Initial ...

Iclusig [millennium pharmaceuticals, inc.]

These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG(ponatinib) tablets, for oral use Initial U.S. Ap...

Idarubicin hydrochloride [west-ward pharmaceuticals corp]

Idarubicin Hydrochloride Injection

Idarubicin hydrochloride [west-ward pharmaceuticals corp]

Idarubicin Hydrochloride Injection

PubMed Articles [1352 Associated PubMed Articles listed on BioPortfolio]

Very rare lineage switch from acute myeloid leukemia to mixed phenotype acute leukemia, B/Myeloid, during chemotherapy with no clonal evolution.

FLT3, a prognostic biomarker for acute myeloid leukemia (AML): Quantitative monitoring with a simple anti-FLT3 interaction and flow cytometric method.

Overexpression of fms-like tyrosine kinase 3 (FLT3) protein in leukemia is highly related to poor prognosis and reduced survival rate in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (...

Molecular cytogenetic characterization of five patients with myeloid leukemia and t(12;22)(p13;q12).

To explore the clinical and laboratory characteristics of 5 patients with myeloid leukemia and t(12;22)(p13;q12).

Analysis of four types of leukemia using Gene Ontology term and Kyoto Encyclopedia of Genes and Genomes pathway enrichment scores.

Leukemia is the second common blood cancer after lymphoma, and its incidence rate has an increasing trend in recent years. Leukemia can be classified into four types: acute lymphoblastic leukemia (ALL...

The applicability of multiparameter flow cytometry for the detection of minimal residual disease using different-from-normal panels to predict relapse in patients with acute myeloid leukemia after allogeneic transplantation.

The MRD status detected using multiparameter flow cytometry (MFC) before allogeneic hematopoietic stem cell transplantation (allo-HSCT) has crucial prognostic value for patients with acute myeloid leu...

Clinical Trials [4864 Associated Clinical Trials listed on BioPortfolio]

"Validation and Reability of the Munich Shoulder Questionnaire Into Turkish Patients"

The purpose of this study was to translate and culturally adapt the MSQ to Turkish language and test the validity and reliability of Turkish version of MSQ in shoulder dysfunction patients...

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia

This phase I/II trial studies the side effects and best dose of laboratory treated T cells to see how well they work in treating patients with chronic lymphocytic leukemia, non-Hodgkin lym...

Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors predict response in patients previously treated with interleukin-2. ...

Metabolic Changes in Blood Samples From Patients With Acute Myeloid Leukemia

This research trial studies metabolic changes in blood samples from patients with acute myeloid leukemia. Studying samples of blood from patients with acute myeloid leukemia in the laborat...

Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia

RATIONALE: Collecting and storing samples of bone marrow and blood from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and ...

Companies [1127 Associated Companies listed on BioPortfolio]

Munich Leukemia Laboratory

The Leukemia & Lymphoma Society (LLS)

The Leukemia & Lymphoma Society (® )(LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improv...

Washington Gas and Leukemia & Lymphoma Society (LLS)

The Leukemia & Lymphoma Society ® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkinâ€...

The Leukemia & Lymphoma Society and Reliant Energy

The Leukemia & Lymphoma Society ® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkinâ€...

Windsor Health Group

Windsor Health GroupSM refers to Windsor Health Group, Inc., an insurance holding company and its operating subsidiaries, which include Windsor Health Plans, Inc. (WHP), and Sterl...

More Information about "Munich Leukemia Laboratory" on BioPortfolio

We have published hundreds of Munich Leukemia Laboratory news stories on BioPortfolio along with dozens of Munich Leukemia Laboratory Clinical Trials and PubMed Articles about Munich Leukemia Laboratory for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Munich Leukemia Laboratory Companies in our database. You can also find out about relevant Munich Leukemia Laboratory Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record